What If I Don't Qualify for Transplant? for AML Patients
Bone marrow transplant (BMT) is currently the only curative treatment for AML patients. But what if you don't qualify for transplant? Dr. Brittany Ragon joins us to talk about what options AML patients have when transplant is not an option.
Mary introduces the agenda for the event and featured speaker Dr. Brittany Ragon
Dr. Brittany Ragon talks about what options AML patients have when transplant is not available
Type your questions in the chat and we will answer them!
Mary Arnett
Mary joined HealthTree in 2022 as a part of HealthTree's team to help expand into all blood cancers. She now works as HealthTree's Volunteer & Community Outreach Manager, helping to engage and involve community members in HealthTree's mission. When she isn't working, she loves being the fun aunt to her 13 nieces and nephews, attending concerts, experimenting with new recipes in the kitchen, and traveling to explore new cities.
Dr. Brittany Ragon
Dr. Brittany Knick Ragon is an Associate Professor in the Department of Internal Medicine at Wake Forest University School of Medicine and Director of Hematology Operations at Levine Cancer Institute in Charlotte, North Carolina. She joined the Leukemia Division at Atrium Health Levine Cancer in 2017 as an adult leukemia and transplant specialist. Her clinical expertise is in acute leukemias, myeloid diseases, allogeneic transplant, hereditary hematologic predisposition syndromes, and bone marrow failure syndromes. Her research is focused on utilizing protein and gene exploration to identify biologically informed therapeutic targets for myeloid malignancies. Through increased understanding of the molecular and genetic landscape of myelodysplastic syndromes and acute leukemias, she aims to find markers for response prediction, toxicity limitation, and to optimize currently available and novel therapeutics. She also has a complementary research focus in efforts to mitigate healthcare disparities in acute leukemia patients. In addition to her translational work, she serves as principal investigator on several clinical trials in acute leukemias. For her research efforts, she has received grant funding from the Leukemia Research Foundation, Shannon Timmons Fellowship for Leukemia Research, and Swim Across America.